- Home
- MOGO vs IGC Comparison
MOGO vs IGC Comparison
Compare MOGO & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- IGC
- Stock Information
- Founded
- MOGO 2003
- IGC 2005
- Country
- MOGO Canada
- IGC United States
- Employees
- MOGO N/A
- IGC N/A
- Industry
- MOGO
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- IGC Health Care
- Exchange
- MOGO Nasdaq
- IGC Nasdaq
- Market Cap
- MOGO 42.5M
- IGC 39.8M
- IPO Year
- MOGO N/A
- IGC N/A
- Fundamental
- Price
- MOGO $1.86
- IGC $0.41
- Analyst Decision
- MOGO Strong Buy
- IGC Strong Buy
- Analyst Count
- MOGO 1
- IGC 2
- Target Price
- MOGO $4.00
- IGC $4.00
- AVG Volume (30 Days)
- MOGO 255.0K
- IGC 1.3M
- Earning Date
- MOGO 11-05-2025
- IGC 11-11-2025
- Dividend Yield
- MOGO N/A
- IGC N/A
- EPS Growth
- MOGO N/A
- IGC N/A
- EPS
- MOGO 0.12
- IGC N/A
- Revenue
- MOGO $30,265,570.00
- IGC $1,327,000.00
- Revenue This Year
- MOGO $61.97
- IGC $15.26
- Revenue Next Year
- MOGO $4.03
- IGC $3.41
- P/E Ratio
- MOGO $15.97
- IGC N/A
- Revenue Growth
- MOGO 0.18
- IGC 24.95
- 52 Week Low
- MOGO $0.74
- IGC $0.25
- 52 Week High
- MOGO $3.83
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- MOGO 54.71
- IGC 51.81
- Support Level
- MOGO $1.78
- IGC $0.38
- Resistance Level
- MOGO $1.92
- IGC $0.44
- Average True Range (ATR)
- MOGO 0.08
- IGC 0.03
- MACD
- MOGO 0.00
- IGC -0.00
- Stochastic Oscillator
- MOGO 70.00
- IGC 32.33
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.